Zenotech Laboratories
Zenotech Laboratories Limited is an India-based pharmaceutical company operating out of Hyderabad, India. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. It specializes in manufacturing Oncology, bio-technology, and General Injectables products, primarily serving niche therapy areas like oncology and anesthesiology. The company manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). Its mission is to develop and manufacture high-quality, affordable pharmaceutical and bio-pharmaceutical products to enhance global health, driven by science, guided by ethics, and focused on improving patients' lives worldwide.
Industries
Nr. of Employees
medium (51-250)
Zenotech Laboratories
Survey no 250 -252, Turkapally village, Shameerpet Mandal, RR District, Telangana – 500 078
Products
Granulocyte colony-stimulating factor (G-CSF) injectable
Biologic growth-factor product manufactured as an injectable formulation (referenced as part of the company's biologics/injectable portfolio).
Granulocyte-macrophage colony-stimulating factor (GM-CSF) injectable
Biologic growth-factor product manufactured as an injectable formulation (referenced as part of the company's biologics/injectable portfolio).
Specialty generic injectable and ophthalmic product portfolio
Portfolio of generic injectable products serving oncology and anesthesiology niches, plus ophthalmic gels and eye-drop presentations.
Granulocyte colony-stimulating factor (G-CSF) injectable
Biologic growth-factor product manufactured as an injectable formulation (referenced as part of the company's biologics/injectable portfolio).
Granulocyte-macrophage colony-stimulating factor (GM-CSF) injectable
Biologic growth-factor product manufactured as an injectable formulation (referenced as part of the company's biologics/injectable portfolio).
Specialty generic injectable and ophthalmic product portfolio
Portfolio of generic injectable products serving oncology and anesthesiology niches, plus ophthalmic gels and eye-drop presentations.
Services
End-to-end manufacture and commercial supply of injectable pharmaceuticals focused on oncology, biologics and general injectables.
End-to-end manufacture and commercial supply of injectable pharmaceuticals focused on oncology, biologics and general injectables.
Expertise Areas
- Specialty generic injectables
- Oncology product manufacturing
- Biologics/biopharmaceutical production
- Sterile aseptic fill-finish
Key Technologies
- Aseptic fill-finish (vials and pre-filled syringes)
- Lyophilization / freeze-drying
- Recombinant protein biologics production
- Microsphere / particulate controlled-release formulation
News & Updates
The company announced the outcome of its board meeting held on July 28, 2025.
The company announced the outcome of its board meeting held on July 28, 2025.